Eastwood Bio-Medical Canada (TSXV:EBM) EPS (Basic): C$-0.03 (TTM As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSXV:EBM Eastwood Bio-Medical Canada Inc TSXV:EBM
25 GF Score
Price C$0.99
GF Value C$0.53
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Eastwood Bio-Medical Canada EPS (Basic)?

Eastwood Bio-Medical Canada TSXV:EBM +1.02% 25 EPS (Basic) is C$-0.03 as of Apr. 2026. GuruFocus rates TSXV:EBM with a GF Score™ of 25/100 and a GF Value™ of C$0.53 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Eastwood Bio-Medical Canada's basic earnings per share (Basic EPS) for the three months ended in Apr. 2026 was C$-0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Apr. 2026 was C$-0.03.

Eastwood Bio-Medical Canada's EPS (Diluted) for the three months ended in Apr. 2026 was C$-0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 was C$-0.03.

Eastwood Bio-Medical Canada's EPS without NRI for the three months ended in Apr. 2026 was C$-0.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Apr. 2026 was -0.03.

During the past 3 years, the average EPS without NRI Growth Rate was -71.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was -4.70% per year. During the past 10 years, the average EPS without NRI Growth Rate was -2.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Eastwood Bio-Medical Canada's highest 3-Year average EPS without NRI Growth Rate was 41.50% per year. The lowest was -71.00% per year. And the median was 0.00% per year.

Eastwood Bio-Medical Canada  (TSXV:EBM) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Eastwood Bio-Medical Canada EPS (Basic) Related Terms

Eastwood Bio-Medical Canada EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Eastwood Bio-Medical Canada's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eastwood Bio-Medical Canada EPS (Basic) Chart

Eastwood Bio-Medical Canada Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 -0.00 -0.01 -0.01 -0.01

Eastwood Bio-Medical Canada Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.01 0.00 -0.01 -0.01
TSXV:EBM
25GF Score
Eastwood Bio-Medical Canada Inc TSXV:EBM
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eastwood Bio-Medical Canada EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Eastwood Bio-Medical Canada's Basic EPS for the fiscal year that ended in Oct. 2025 is calculated as

Basic EPS (A: Oct. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.333-0)/68.886
=-0.00

Eastwood Bio-Medical Canada's Basic EPS for the quarter that ended in Apr. 2026 is calculated as

Basic EPS (Q: Apr. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.066-0)/68.886
=-0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of C$-0.03 mean?
Eastwood Bio-Medical Canada (TSXV:EBM) has a EPS (Basic) of C$-0.03 as of Apr. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Eastwood Bio-Medical Canada and its competitors.
Is Eastwood Bio-Medical Canada's EPS (Basic) too high?
Eastwood Bio-Medical Canada's current EPS (Basic) is C$-0.03. Overall, Eastwood Bio-Medical Canada has a GF Score™ of 25/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Eastwood Bio-Medical Canada's EPS (Basic) compare to VRTX and REGN?
Eastwood Bio-Medical Canada's EPS (Basic) of C$-0.03 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Eastwood Bio-Medical Canada and its competitors. Eastwood Bio-Medical Canada's current EPS (Basic) is C$-0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eastwood Bio-Medical Canada stock overvalued right now?
Based on GuruFocus' analysis, Eastwood Bio-Medical Canada (TSXV:EBM) is currently considered Significantly Overvalued. The stock's GF Value™ is C$0.53, compared to a current price of C$0.99 — trading 86.8% above its estimated fair value. The current EPS (Basic) is C$-0.03. Eastwood Bio-Medical Canada's overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Eastwood Bio-Medical Canada (TSXV:EBM), the current EPS (Basic) is C$-0.03 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eastwood Bio-Medical Canada (TSXV:EBM) Overvalued in 2026?

Based on GuruFocus' analysis, Eastwood Bio-Medical Canada stock appears to be overvalued. The current stock price of C$0.99 is trading 86.8% above its estimated GF Value™ of C$0.53. GuruFocus considers Eastwood Bio-Medical Canada to be Significantly Overvalued.

Key valuation signals for TSXV:EBM:

  • EPS (Basic): C$-0.03
  • GF Value™: C$0.53 vs. price of C$0.99 (86.8% above fair value)
  • GF Score™: 25/100 with 4 warning signs

No single metric tells the full story. See the TSXV:EBM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eastwood Bio-Medical Canada Business Description

Address 4871 Shell Road, Suite 1130, Richmond, BC, CAN, V6X 3Z6
Eastwood Bio-Medical Canada Inc is a Canadian company engaged in the development and commercialization of safe and effective treatment for non-insulin dependent diabetes mellitus. The company is engaged in natural health supplement distribution company. It has its geographic presence in U.S., Canada and Asia. The company generates maximum revenue from Asia.
25GF Score

Get the complete analysis for TSXV:EBM

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.99
Price
C$0.53
GF Value